Longitudinal Study of the Porphyrias
NCT01561157 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2026-05-15
Summary
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
Conditions
- Acute Porphyrias
- Cutaneous Porphyrias
Sponsors & Collaborators
-
The American Porphyrias Expert Collaborative
lead OTHER -
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH
Principal Investigators
-
Hetanshi Naik, PhD · Stanford University
Eligibility
- Min Age
- 1 Minute
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-01
- Primary Completion
- 2030-06-30
- Completion
- 2030-06-30
Countries
- United States
Study Locations
More Related Trials
-
Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
NCT00004396 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Intermittent Porphyria Related Abnormalities in Cardiovascular System
NCT05882136 ·Status: COMPLETED
-
Screening Patients With Sickle Cell Disease for Kidney Damage
NCT02239016 ·Status: COMPLETED
-
Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
NCT01294891 ·Status: COMPLETED
-
Acute Porphyria Biomarkers for Disease Activity
NCT02935400 ·Status: ACTIVE_NOT_RECRUITING
-
Kidney Function in Sickle Cell Anemia
NCT03277547 ·Status: ACTIVE_NOT_RECRUITING
-
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
NCT05213572 ·Status: RECRUITING
-
Sickle Cell Clinical Research and Intervention Program
NCT02098863 ·Status: RECRUITING
-
Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
NCT00011648 ·Status: COMPLETED
-
Identification of Acute Intermittent Porphyria Modifying Genes
NCT05502133 ·Status: RECRUITING
-
Cooperative Study of The Clinical Course of Sickle Cell Disease
NCT00005277 ·Status: COMPLETED
-
Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)
NCT01617642 ·Status: ACTIVE_NOT_RECRUITING
-
Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
NCT00004397 ·Status: COMPLETED ·Phase: PHASE1
-
SCRIPT: Sickle Cell Risk in Pregnancy Tool
NCT06529042 ·Status: ENROLLING_BY_INVITATION
-
Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
NCT00004940 ·Status: COMPLETED ·Phase: PHASE3
-
Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease
NCT04205123 ·Status: UNKNOWN
-
The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
NCT05214105 ·Status: RECRUITING
-
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
NCT00305175 ·Status: COMPLETED
-
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
NCT00102245 ·Status: TERMINATED
-
Cardiovascular Complications of Sickle Cell Disease
NCT01044901 ·Status: COMPLETED
-
Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
NCT00004831 ·Status: COMPLETED ·Phase: NA
-
BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension
NCT04086537 ·Status: COMPLETED
-
Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
NCT00004398 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
NCT01558076 ·Status: COMPLETED
-
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
NCT01220115 ·Status: COMPLETED